A 26-gene hypoxia signature predicts benefit from hypoxia-modifying therapy in laryngeal cancer but not bladder cancer.

A 26-gene hypoxia signature predicts benefit from hypoxia-modifying therapy in laryngeal cancer but not bladder cancer.

PURPOSE: Tumor hypoxia is associated with a poor prognosis, hypoxia modification improves outcome, and hypoxic status predicts benefit from treatment. Yet, there is no universal measure of clinical hypoxia. The aim of this study was to investigate whether a 26-gene hypoxia signature predicted benefi...

Bibliografski detalji
Glavni autori:	Eustace, A, Mani, N, Span, P, Irlam, J, Taylor, J, Betts, G, Denley, H, Miller, C, Homer, J, Rojas, A, Hoskin, P, Buffa, F, Harris, A, Kaanders, J, West, C
Format:	Journal article
Jezik:	English
Izdano:	2013

Slični predmeti

Expression of miR-210 in relation to other measures of hypoxia and prediction of benefit from hypoxia modification in patients with bladder cancer
od: Irlam-Jones, J, i dr.
Izdano: (2016)

A gene signature for selecting benefit from hypoxia modification of radiotherapy for high risk bladder cancer patients
od: Yang, L, i dr.
Izdano: (2017)

Necrosis predicts benefit from hypoxia-modifying therapy in patients with high risk bladder cancer enrolled in a phase III randomised trial
od: Eustace, A, i dr.
Izdano: (2013)

Necrosis predicts benefit from hypoxia-modifying therapy in patients with high risk bladder cancer enrolled in a phase III randomised trial.
od: Eustace, A, i dr.
Izdano: (2013)

Prospective technical validation and assessment of intra-tumour heterogeneity of a low density array hypoxia gene profile in head and neck squamous cell carcinoma.
od: Betts, G, i dr.
Izdano: (2013)

Prospective technical validation and assessment of intra-tumour heterogeneity of a low density array hypoxia gene profile in head and neck squamous cell carcinoma
od: Betts, G, i dr.
Izdano: (2013)

The effect of hypoxia on PD-L1 expression in bladder cancer
od: Vicky Smith, i dr.
Izdano: (2021-11-01)

Hypoxia regulated miRNAs in bladder cancer
od: Blick, C, i dr.
Izdano: (2012)

hsa-mir-210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer.
od: Gee, H, i dr.
Izdano: (2010)

The role of hypoxia regulated microRNAs in cancer.
od: McCormick, R, i dr.
Izdano: (2010)

Relation of a hypoxia metagene derived from head and neck cancer to prognosis of multiple cancers.
od: Winter, S, i dr.
Izdano: (2007)

Gene expression and hypoxia in breast cancer.
od: Favaro, E, i dr.
Izdano: (2011)

Exon array analysis of head and neck cancers identifies a hypoxia related splice variant of LAMA3 associated with a poor prognosis
od: Moller-Levet, C, i dr.
Izdano: (2009)

Hypoxia and oxidative stress in breast cancer. Hypoxia signalling pathways.
od: Pugh, C, i dr.
Izdano: (2001)

Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene.
od: Buffa, F, i dr.
Izdano: (2010)

Gene expression signatures as biomarkers of tumour hypoxia
od: Harris, B, i dr.
Izdano: (2015)

Hypoxia and HIF pathway in cancer and the placenta
od: Macklin, P, i dr.
Izdano: (2017)

An in vivo hypoxia metagene identifies the novel hypoxia inducible factor target gene SLCO1B3.
od: Ramachandran, A, i dr.
Izdano: (2013)

An in vivo hypoxia metagene identifies the novel hypoxia inducible factor target gene SLCO1B3
od: Ramachandran, A, i dr.
Izdano: (2013)

Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis.
od: Jubb, A, i dr.
Izdano: (2010)

Imaging hypoxia in endometrial cancer: How and why should it be done?
od: Nandita M. deSouza, i dr.
Izdano: (2022-11-01)

An investigation into the prognostic significance of necrosis and hypoxia in high grade and invasive bladder cancer.
od: Ord, J, i dr.
Izdano: (2007)

Comparison of hypoxia transcriptome in vitro with in vivo gene expression in human bladder cancer.
od: Ord, J, i dr.
Izdano: (2005)

The hypoxia-inducible genes VEGF and CA9 are differentially regulated in superficial vs invasive bladder cancer.
od: Turner, K, i dr.
Izdano: (2002)

An investigation into the prognostic significance of necrosis and hypoxia in high grade and invasive bladder cancer
od: Ord, J, i dr.
Izdano: (2007)

hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer.
od: Camps, C, i dr.
Izdano: (2008)

Hypoxia and oxidative stress in breast cancer. Hypoxia and tumourigenesis
od: Knowles, H, i dr.
Izdano: (2001)

Hypoxia and oxidative stress in breast cancer. Hypoxia and tumourigenesis.
od: Knowles, H, i dr.
Izdano: (2001)

In vitro downregulated hypoxia transcriptome is associated with poor prognosis in breast cancer
od: Abu-Jamous, B, i dr.
Izdano: (2017)

Exon array analysis of head and neck cancers identifies a hypoxia related splice variant of LAMA3 associated with a poor prognosis.
od: Carla S Moller-Levet, i dr.
Izdano: (2009-11-01)

Defining the role of AP1 in molecular adaptation to hypoxia in colorectal cancer
od: Vancauwenberghe, E, i dr.
Izdano: (2019)

Influence of hypoxia and neoangiogenesis on the growth of pancreatic cancer
od: Reber Howard A, i dr.
Izdano: (2003-01-01)

Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene (British Journal of Cancer (2010) 102 (428435) DOI:10.1038/sj.bjc.6605450))
od: Buffa, F, i dr.
Izdano: (2010)

Multimodal evaluation of hypoxia in brain metastases of lung cancer and interest of hypoxia image-guided radiotherapy
od: Corroyer-Dulmont, A, i dr.
Izdano: (2021)

Digital spatial profiling of the microenvironment of muscle invasive bladder cancer
od: Michael Eyers, i dr.
Izdano: (2024-06-01)

The prognosis of bladder cancer is affected by fatty acid metabolism, inflammation, and hypoxia
od: Yu Xiao, i dr.
Izdano: (2022-11-01)

Hypoxia regulates FGFR3 expression via HIF-1α and miR-100 and contributes to cell survival in non-muscle invasive bladder cancer
od: Blick, C, i dr.
Izdano: (2013)

Hypoxia regulates FGFR3 expression via HIF-1α and miR-100 and contributes to cell survival in non-muscle invasive bladder cancer.
od: Blick, C, i dr.
Izdano: (2013)

Targeting Hypoxia: Hypoxia-Activated Prodrugs in Cancer Therapy
od: Yue Li, i dr.
Izdano: (2021-07-01)

Erratum: Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene (British Journal of Cancer (2010) 102 (428-435) DOI: 10.1038/sj.bjc.6605450)
od: Buffa, F, i dr.
Izdano: (2010)